David P Dearnaley

David P Dearnaley

UNVERIFIED PROFILE

Are you David P Dearnaley?   Register this Author

Register author
David P Dearnaley

David P Dearnaley

Publications by authors named "David P Dearnaley"

Are you David P Dearnaley?   Register this Author

99Publications

3268Reads

29Profile Views

Patterns of recurrence after prostate bed radiotherapy.

Radiother Oncol 2019 Sep 25. Epub 2019 Sep 25.

Urological Oncology Department, Royal Marsden Hospital, London & Sutton, UK; Radiotherapy and Imaging Division, Institute of Cancer Research, London & Sutton, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2019.09.007DOI Listing
September 2019

In Regard to Spratt.

Int J Radiat Oncol Biol Phys 2018 12;102(5):1596-1597

Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.08.007DOI Listing
December 2018

Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.

Int J Radiat Oncol Biol Phys 2018 06 3;101(2):309-315. Epub 2018 Feb 3.

Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden, Sutton, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.01.072DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947826PMC
June 2018

Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy.

Br J Radiol 2018 Apr 5;91(1084):20170795. Epub 2018 Feb 5.

2 Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust , London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20170795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966004PMC
April 2018

Reply to 'Single high dose versus repeated bone-targeted radionuclide therapy'.

Eur J Nucl Med Mol Imaging 2018 03;45(3):515-517

Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3902-2DOI Listing
March 2018

Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.

Int J Radiat Oncol Biol Phys 2017 12 2;99(5):1234-1242. Epub 2017 Aug 2.

Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom; Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.07.041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697895PMC
December 2017

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

N Engl J Med 2017 07 3;377(4):338-351. Epub 2017 Jun 3.

From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1702900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533216PMC
July 2017

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.

J Clin Oncol 2017 May 13;35(14):1530-1541. Epub 2017 Mar 13.

Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455701PMC
May 2017

Phase I/II trials of Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival.

Eur J Nucl Med Mol Imaging 2017 Apr 21;44(4):620-629. Epub 2016 Oct 21.

Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-016-3543-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323472PMC
April 2017

A radiobiological model of metastatic burden reduction for molecular radiotherapy: application to patients with bone metastases.

Phys Med Biol 2017 04;62(7):2859-2870

Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6560/aa5e6fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953197PMC
April 2017

The Role of Hypofractionated Radiotherapy in Prostate Cancer.

Curr Oncol Rep 2017 Apr;19(4):30

Division of Radiotherapy and Imaging, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton Surrey, SM2 5PT, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0584-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366169PMC
April 2017

Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity-modulated radiation therapy and volumetric modulated arc therapy for prostate cancer.

Radiother Oncol 2016 08 25;120(2):320-6. Epub 2016 Jul 25.

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.07.004DOI Listing
August 2016

Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.

Eur Urol 2016 07 2;70(1):e10. Epub 2016 Mar 2.

Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.02.044DOI Listing
July 2016

Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort.

Eur Urol 2016 06 21;69(6):1028-33. Epub 2015 Oct 21.

Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.10.010DOI Listing
June 2016

Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?

Cancer Manag Res 2015 11;7:331-44. Epub 2015 Nov 11.

Academic Urology Unit, Institute of Cancer Research, London ; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMAR.S51955DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646477PMC
December 2015

The role of 18F-FDG PET/CT in the management of testicular cancers.

Nucl Med Commun 2015 Jul;36(7):702-8

aKings College London bRoyal Marsden NHS Foundation Trust, London cInstitute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000303DOI Listing
July 2015

Hypofractionated radiotherapy in prostate cancer.

Lancet Oncol 2015 Mar 3;16(3):237-8. Epub 2015 Feb 3.

Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SM2 5NG, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045157002
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(15)70021-5DOI Listing
March 2015

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.

Nat Genet 2014 Aug 29;46(8):891-4. Epub 2014 Jun 29.

1] Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain. [2] Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3020DOI Listing
August 2014

Coplanar intensity-modulated radiotherapy class solution for patients with prostate cancer with bilateral hip prostheses with and without nodal involvement.

Med Dosim 2013 21;38(2):165-70. Epub 2012 Dec 21.

Joint Department of Physics, The Royal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09583947120018
Publisher Site
http://dx.doi.org/10.1016/j.meddos.2012.10.007DOI Listing
December 2013

Medium-term outcomes of active surveillance for localised prostate cancer.

Eur Urol 2013 Dec 18;64(6):981-7. Epub 2013 Feb 18.

The Royal Marsden Hospital, Sutton, Surrey, UK; The Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2013.02.020DOI Listing
December 2013

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.

Authors:
Rosalind A Eeles Ali Amin Al Olama Sara Benlloch Edward J Saunders Daniel A Leongamornlert Malgorzata Tymrakiewicz Maya Ghoussaini Craig Luccarini Joe Dennis Sarah Jugurnauth-Little Tokhir Dadaev David E Neal Freddie C Hamdy Jenny L Donovan Ken Muir Graham G Giles Gianluca Severi Fredrik Wiklund Henrik Gronberg Christopher A Haiman Fredrick Schumacher Brian E Henderson Loic Le Marchand Sara Lindstrom Peter Kraft David J Hunter Susan Gapstur Stephen J Chanock Sonja I Berndt Demetrius Albanes Gerald Andriole Johanna Schleutker Maren Weischer Federico Canzian Elio Riboli Tim J Key Ruth C Travis Daniele Campa Sue A Ingles Esther M John Richard B Hayes Paul D P Pharoah Nora Pashayan Kay-Tee Khaw Janet L Stanford Elaine A Ostrander Lisa B Signorello Stephen N Thibodeau Dan Schaid Christiane Maier Walther Vogel Adam S Kibel Cezary Cybulski Jan Lubinski Lisa Cannon-Albright Hermann Brenner Jong Y Park Radka Kaneva Jyotsna Batra Amanda B Spurdle Judith A Clements Manuel R Teixeira Ed Dicks Andrew Lee Alison M Dunning Caroline Baynes Don Conroy Melanie J Maranian Shahana Ahmed Koveela Govindasami Michelle Guy Rosemary A Wilkinson Emma J Sawyer Angela Morgan David P Dearnaley Alan Horwich Robert A Huddart Vincent S Khoo Christopher C Parker Nicholas J Van As Christopher J Woodhouse Alan Thompson Tim Dudderidge Chris Ogden Colin S Cooper Artitaya Lophatananon Angela Cox Melissa C Southey John L Hopper Dallas R English Markus Aly Jan Adolfsson Jiangfeng Xu Siqun L Zheng Meredith Yeager Rudolf Kaaks W Ryan Diver Mia M Gaudet Mariana C Stern Roman Corral Amit D Joshi Ahva Shahabi Tiina Wahlfors Teuvo L J Tammela Anssi Auvinen Jarmo Virtamo Peter Klarskov Børge G Nordestgaard M Andreas Røder Sune F Nielsen Stig E Bojesen Afshan Siddiq Liesel M Fitzgerald Suzanne Kolb Erika M Kwon Danielle M Karyadi William J Blot Wei Zheng Qiuyin Cai Shannon K McDonnell Antje E Rinckleb Bettina Drake Graham Colditz Dominika Wokolorczyk Robert A Stephenson Craig Teerlink Heiko Muller Dietrich Rothenbacher Thomas A Sellers Hui-Yi Lin Chavdar Slavov Vanio Mitev Felicity Lose Srilakshmi Srinivasan Sofia Maia Paula Paulo Ethan Lange Kathleen A Cooney Antonis C Antoniou Daniel Vincent François Bacot Daniel C Tessier Zsofia Kote-Jarai Douglas F Easton

Nat Genet 2013 Apr;45(4):385-91, 391e1-2

The Institute of Cancer Research, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832790PMC
April 2013

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.

Authors:
Ali Amin Al Olama Zsofia Kote-Jarai Fredrick R Schumacher Fredrik Wiklund Sonja I Berndt Sara Benlloch Graham G Giles Gianluca Severi David E Neal Freddie C Hamdy Jenny L Donovan David J Hunter Brian E Henderson Michael J Thun Michael Gaziano Edward L Giovannucci Afshan Siddiq Ruth C Travis David G Cox Federico Canzian Elio Riboli Timothy J Key Gerald Andriole Demetrius Albanes Richard B Hayes Johanna Schleutker Anssi Auvinen Teuvo L J Tammela Maren Weischer Janet L Stanford Elaine A Ostrander Cezary Cybulski Jan Lubinski Stephen N Thibodeau Daniel J Schaid Karina D Sorensen Jyotsna Batra Judith A Clements Suzanne Chambers Joanne Aitken Robert A Gardiner Christiane Maier Walther Vogel Thilo Dörk Hermann Brenner Tomonori Habuchi Sue Ingles Esther M John Joanne L Dickinson Lisa Cannon-Albright Manuel R Teixeira Radka Kaneva Hong-Wei Zhang Yong-Jie Lu Jong Y Park Kathleen A Cooney Kenneth R Muir Daniel A Leongamornlert Edward Saunders Malgorzata Tymrakiewicz Nadiya Mahmud Michelle Guy Koveela Govindasami Lynne T O'Brien Rosemary A Wilkinson Amanda L Hall Emma J Sawyer Tokhir Dadaev Jonathan Morrison David P Dearnaley Alan Horwich Robert A Huddart Vincent S Khoo Christopher C Parker Nicholas Van As Christopher J Woodhouse Alan Thompson Tim Dudderidge Chris Ogden Colin S Cooper Artitaya Lophatonanon Melissa C Southey John L Hopper Dallas English Jarmo Virtamo Loic Le Marchand Daniele Campa Rudolf Kaaks Sara Lindstrom W Ryan Diver Susan Gapstur Meredith Yeager Angela Cox Mariana C Stern Roman Corral Markus Aly William Isaacs Jan Adolfsson Jianfeng Xu S Lilly Zheng Tiina Wahlfors Kimmo Taari Paula Kujala Peter Klarskov Børge G Nordestgaard M Andreas Røder Ruth Frikke-Schmidt Stig E Bojesen Liesel M FitzGerald Suzanne Kolb Erika M Kwon Danielle M Karyadi Torben Falck Orntoft Michael Borre Antje Rinckleb Manuel Luedeke Kathleen Herkommer Andreas Meyer Jürgen Serth James R Marthick Briony Patterson Dominika Wokolorczyk Amanda Spurdle Felicity Lose Shannon K McDonnell Amit D Joshi Ahva Shahabi Pedro Pinto Joana Santos Ana Ray Thomas A Sellers Hui-Yi Lin Robert A Stephenson Craig Teerlink Heiko Muller Dietrich Rothenbacher Norihiko Tsuchiya Shintaro Narita Guang-Wen Cao Chavdar Slavov Vanio Mitev Stephen Chanock Henrik Gronberg Christopher A Haiman Peter Kraft Douglas F Easton Rosalind A Eeles

Hum Mol Genet 2013 Jan 12;22(2):408-15. Epub 2012 Oct 12.

Strangeways Laboratory, Centre for Cancer Genetic Epidemiology, Worts Causeway, Cambridge CB1 8RN, UK.

View Article

Download full-text PDF

Source
http://hmg.oxfordjournals.org/content/22/2/408.full.pdf
Web Search
http://www.hmg.oxfordjournals.org/cgi/doi/10.1093/hmg/dds425
Publisher Site
http://dx.doi.org/10.1093/hmg/dds425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526158PMC
January 2013

The dose-response of the anal sphincter region--an analysis of data from the MRC RT01 trial.

Radiother Oncol 2012 Jun 18;103(3):347-52. Epub 2012 Apr 18.

Joint Department of Physics, Institute of Cancer Research, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2012.03.002DOI Listing
June 2012

Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise.

Radiother Oncol 2012 Mar 25;102(3):347-51. Epub 2011 Nov 25.

Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2011.10.022DOI Listing
March 2012

Can diet combined with treatment scheduling achieve consistency of rectal filling in patients receiving radiotherapy to the prostate?

Radiother Oncol 2011 Dec 6;101(3):471-8. Epub 2011 Sep 6.

Department of Radiotherapy, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2011.08.003DOI Listing
December 2011

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.

Authors:
Zsofia Kote-Jarai Ali Amin Al Olama Graham G Giles Gianluca Severi Johanna Schleutker Maren Weischer Daniele Campa Elio Riboli Tim Key Henrik Gronberg David J Hunter Peter Kraft Michael J Thun Sue Ingles Stephen Chanock Demetrius Albanes Richard B Hayes David E Neal Freddie C Hamdy Jenny L Donovan Paul Pharoah Fredrick Schumacher Brian E Henderson Janet L Stanford Elaine A Ostrander Karina Dalsgaard Sorensen Thilo Dörk Gerald Andriole Joanne L Dickinson Cezary Cybulski Jan Lubinski Amanda Spurdle Judith A Clements Suzanne Chambers Joanne Aitken R A Frank Gardiner Stephen N Thibodeau Dan Schaid Esther M John Christiane Maier Walther Vogel Kathleen A Cooney Jong Y Park Lisa Cannon-Albright Hermann Brenner Tomonori Habuchi Hong-Wei Zhang Yong-Jie Lu Radka Kaneva Ken Muir Sara Benlloch Daniel A Leongamornlert Edward J Saunders Malgorzata Tymrakiewicz Nadiya Mahmud Michelle Guy Lynne T O'Brien Rosemary A Wilkinson Amanda L Hall Emma J Sawyer Tokhir Dadaev Jonathan Morrison David P Dearnaley Alan Horwich Robert A Huddart Vincent S Khoo Christopher C Parker Nicholas Van As Christopher J Woodhouse Alan Thompson Tim Christmas Chris Ogden Colin S Cooper Aritaya Lophatonanon Melissa C Southey John L Hopper Dallas R English Tiina Wahlfors Teuvo L J Tammela Peter Klarskov Børge G Nordestgaard M Andreas Røder Anne Tybjærg-Hansen Stig E Bojesen Ruth Travis Federico Canzian Rudolf Kaaks Fredrik Wiklund Markus Aly Sara Lindstrom W Ryan Diver Susan Gapstur Mariana C Stern Roman Corral Jarmo Virtamo Angela Cox Christopher A Haiman Loic Le Marchand Liesel Fitzgerald Suzanne Kolb Erika M Kwon Danielle M Karyadi Torben Falck Orntoft Michael Borre Andreas Meyer Jürgen Serth Meredith Yeager Sonja I Berndt James R Marthick Briony Patterson Dominika Wokolorczyk Jyotsna Batra Felicity Lose Shannon K McDonnell Amit D Joshi Ahva Shahabi Antje E Rinckleb Ana Ray Thomas A Sellers Hui-Yi Lin Robert A Stephenson James Farnham Heiko Muller Dietrich Rothenbacher Norihiko Tsuchiya Shintaro Narita Guang-Wen Cao Chavdar Slavov Vanio Mitev Douglas F Easton Rosalind A Eeles

Nat Genet 2011 Jul 10;43(8):785-91. Epub 2011 Jul 10.

The Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.882DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396006PMC
July 2011

Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer.

Cancer 2010 May;116(10):2322-31

Urology Unit, The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24981DOI Listing
May 2010

Serum micronutrient and antioxidant levels at baseline and the natural history of men with localised prostate cancer on active surveillance.

Tumour Biol 2010 Apr 16;31(2):97-102. Epub 2010 Feb 16.

Department of Clinical Oncology, Ipswich Hospital NHS Trust, Ipswich, Suffolk, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-009-0013-0DOI Listing
April 2010

Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397.

Int J Radiat Oncol Biol Phys 2010 Mar 18;76(3):747-54. Epub 2009 Jun 18.

Joint Department of Physics, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, Sutton, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.02.025DOI Listing
March 2010

A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity.

Radiother Oncol 2010 Feb 22;94(2):241-7. Epub 2010 Jan 22.

Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2009.12.019DOI Listing
February 2010

A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance.

Eur Urol 2009 Dec 6;56(6):981-7. Epub 2008 Dec 6.

Academic Unit of Radiotherapy and Oncology, Department of Radiology, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838080138
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2008.11.051DOI Listing
December 2009

Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397).

Phys Med Biol 2009 Nov 14;54(21):6535-48. Epub 2009 Oct 14.

Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/0031-9155/54/21/006DOI Listing
November 2009

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.

Authors:
Rosalind A Eeles Zsofia Kote-Jarai Ali Amin Al Olama Graham G Giles Michelle Guy Gianluca Severi Kenneth Muir John L Hopper Brian E Henderson Christopher A Haiman Johanna Schleutker Freddie C Hamdy David E Neal Jenny L Donovan Janet L Stanford Elaine A Ostrander Sue A Ingles Esther M John Stephen N Thibodeau Daniel Schaid Jong Y Park Amanda Spurdle Judith Clements Joanne L Dickinson Christiane Maier Walther Vogel Thilo Dörk Timothy R Rebbeck Kathleen A Cooney Lisa Cannon-Albright Pierre O Chappuis Pierre Hutter Maurice Zeegers Radka Kaneva Hong-Wei Zhang Yong-Jie Lu William D Foulkes Dallas R English Daniel A Leongamornlert Malgorzata Tymrakiewicz Jonathan Morrison Audrey T Ardern-Jones Amanda L Hall Lynne T O'Brien Rosemary A Wilkinson Edward J Saunders Elizabeth C Page Emma J Sawyer Stephen M Edwards David P Dearnaley Alan Horwich Robert A Huddart Vincent S Khoo Christopher C Parker Nicholas Van As Christopher J Woodhouse Alan Thompson Tim Christmas Chris Ogden Colin S Cooper Melissa C Southey Artitaya Lophatananon Jo-Fen Liu Laurence N Kolonel Loic Le Marchand Tiina Wahlfors Teuvo L Tammela Anssi Auvinen Sarah J Lewis Angela Cox Liesel M FitzGerald Joseph S Koopmeiners Danielle M Karyadi Erika M Kwon Mariana C Stern Roman Corral Amit D Joshi Ahva Shahabi Shannon K McDonnell Thomas A Sellers Julio Pow-Sang Suzanne Chambers Joanne Aitken R A Frank Gardiner Jyotsna Batra Mary Anne Kedda Felicity Lose Andrea Polanowski Briony Patterson Jürgen Serth Andreas Meyer Manuel Luedeke Klara Stefflova Anna M Ray Ethan M Lange Jim Farnham Humera Khan Chavdar Slavov Atanaska Mitkova Guangwen Cao Douglas F Easton

Nat Genet 2009 Oct 20;41(10):1116-21. Epub 2009 Sep 20.

The Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846760PMC
October 2009

Additional therapy for high-risk prostate cancer treated with surgery: what is the evidence?

Expert Rev Anticancer Ther 2009 Jul;9(7):939-51

Honorary Clinical Research Fellow, Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.09.60DOI Listing
July 2009

Prospective study of factors predicting adherence to medical advice in men with testicular cancer.

J Clin Oncol 2009 May 23;27(13):2144-50. Epub 2009 Mar 23.

Academic Radiotherapy Unit, The Institute of Cancer Research and Department of Clinical Research Development, Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.16.1901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738633PMC
May 2009

Clinical implications of introducing a new PSA assay.

Int Urol Nephrol 2008 6;40(3):657-61. Epub 2008 Feb 6.

Academic Unit of Radiotherapy & Oncology, Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-007-9330-7DOI Listing
January 2009

Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance.

Eur Urol 2008 Dec 7;54(6):1297-305. Epub 2008 Mar 7.

Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2008.02.039DOI Listing
December 2008

Efficacy of low-dose dexamethasone in castration-refractory prostate cancer.

BJU Int 2008 Feb 17;101(4):440-3. Epub 2007 Oct 17.

Academic Urology Unit, Royal Marsden Hospital, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1464-410X.2007.07261.x
Publisher Site
http://dx.doi.org/10.1111/j.1464-410X.2007.07261.xDOI Listing
February 2008

Evaluation of margining algorithms in commercial treatment planning systems.

Radiother Oncol 2008 Jan 3;86(1):43-7. Epub 2007 Dec 3.

Physics Department, Clatterbridge Centre for Oncology NHS Foundation Trust, Wirral, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2007.11.006DOI Listing
January 2008

Outcome of early detection and radiotherapy for occult spinal cord compression.

Radiother Oncol 2007 Dec 26;85(3):469-72. Epub 2007 Nov 26.

Academic Urology Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2007.10.043DOI Listing
December 2007

Additional treatment for pT3 prostate cancer: now, later or never.

BJU Int 2007 Nov 10;100(5):977-9. Epub 2007 Sep 10.

Academic Radiotherapy, Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2007.07177.xDOI Listing
November 2007

The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours.

BJU Int 2007 Jul;100(1):30-2

Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2007.06905.xDOI Listing
July 2007

Long-term effects of a short course of neoadjuvant luteinizing hormone-releasing hormone analogue and radical radiotherapy on the hormonal profile in patients with localized prostate cancer.

BJU Int 2007 Jun;99(6):1380-2

Academic Unit of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2007.06843.xDOI Listing
June 2007

Tumor dosimetry on SPECT (186)Re-HEDP scans: variations in the results from the reconstruction methods used.

Cancer Biother Radiopharm 2007 Feb;22(1):121-4

Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sulton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cbr.2007.303DOI Listing
February 2007

Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).

Radiother Oncol 2006 Sep 1;80(3):355-62. Epub 2006 Sep 1.

Academic Department of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2006.07.037DOI Listing
September 2006

A comparison of CT- and ultrasound-based imaging to localize the prostate for external beam radiotherapy.

Int J Radiat Oncol Biol Phys 2006 Jul;65(3):678-87

Department of Radiotherapy, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.01.022DOI Listing
July 2006

Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy.

BJU Int 2006 Jul;98(1):67-9

Academic Unit of Radiotherapy & Oncology, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1464-410X.2006.06188.x
Publisher Site
http://dx.doi.org/10.1111/j.1464-410X.2006.06188.xDOI Listing
July 2006

Variability of bladder filling in patients receiving radical radiotherapy to the prostate.

Radiother Oncol 2006 Jun 16;79(3):335-40. Epub 2006 Jun 16.

Radiotherapy Department, Royal Marsden NHS Foundation Trust, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2006.05.007DOI Listing
June 2006

Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer.

BJU Int 2006 Mar;97(3):476-9

Academic Unit of Radiotherapy and Oncology, and Department of Computing and Information, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2006.06013.xDOI Listing
March 2006

The impact of introducing intensity modulated radiotherapy into routine clinical practice.

Radiother Oncol 2005 Dec 17;77(3):241-6. Epub 2005 Nov 17.

Radiotherapy Department, Royal Marsden NHS Foundation Trust, London and Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2005.10.011DOI Listing
December 2005

Treatment planning evaluation of non-coplanar techniques for conformal radiotherapy of the prostate.

Radiother Oncol 2005 Jun;75(3):287-92

Joint Department of Physics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2005.03.023DOI Listing
June 2005

Technological advances in radiotherapy for the treatment of localised prostate cancer.

Eur J Cancer 2005 Apr;41(6):908-21

Academic Unit of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980490500051
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2004.12.028DOI Listing
April 2005

Dose to bone marrow using IMRT techniques in prostate cancer patients.

Strahlenther Onkol 2005 Mar;181(3):172-8

Department of Radiotherapy, Cancer Center, North-Estonian Regional Hospital, Tallinn, Estonia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-005-1360-4DOI Listing
March 2005